Specific CYP3A4 inhibitors in grapefruit juice: Furocoumarin dimers as components of drug interaction

Pharmacogenetics

Volumn 7, Issue 5, 1997, Pages 391-396

  Fukuda, Katsuyuki ^a,b   Ohta, Tomihisa ^a   Oshima, Yoshiteru ^a   Ohashi, Noriko ^b   Yoshikawa, Masayoshi ^b   Yamazoe, Yasushi ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Cytochrome P450 inhibitors; Drug interaction; Furocoumarins; Grapefruit juice

Indexed keywords

CYTOCHROME P450 INHIBITOR; FUROCOUMARIN DERIVATIVE; KETOCONAZOLE;

ARTICLE; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG ISOLATION; DRUG PURIFICATION; ENZYME INHIBITION; FRUIT JUICE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; LIVER; MASS SPECTROMETRY; PRIORITY JOURNAL;

BEVERAGES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CITRUS; CYTOCHROME P-450 ENZYME SYSTEM; DIMERIZATION; DRUG INTERACTIONS; ENZYME INHIBITORS; HUMANS; HYDROXYLATION; MICROSOMES, LIVER; MIXED FUNCTION OXYGENASES; PSORALENS; SPECTRUM ANALYSIS; TESTOSTERONE;

CITRUS X PARADISI; OXY;

EID: 0030868487     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199710000-00008     Document Type: Article

References (30)

1. Bailey DG, Edger B, Spence JD, Munoz C, Arnold JM. Felodipine and nifedipine interactions with grapefuit juice. Clin Pharmacol Ther 1990: 47, 180.
2. Bailey DG, Spence JD, Munoz C, Arnold JM. Interaction of citrus juices with felodipine and nifedipine. Lancet 1991: 337, 268-269.
3. Bailey DG, Arnold JM, Munoz C, Spence JD. Grapefruit juice - felodipine interaction: mechanism, predictability, and effect of naringin. Clin Pharmacol Ther 1993a: 53, 637-642.
4. Bailey DG, Arnold JM, Strong HA, Munoz C, Spence JD. Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics. Clin Pharmacol Ther 1993b: 54, 589-594.
5. Bailey DG, Arnold JM, Spence JD. Grapefruit juice and drugs. How significant is the interaction? Clin Pharmacokinet 1994: 26, 91-98.
6. Benton R, Honig P, Zamani K, Hewett J, Cantilena LR, Woosley RL. Grapefruit juice alters terfenadine pharmacokinetics resulting in prolongation of QTc. Clin Pharmacol Ther 1994: 55, 146.
7. 1 metabolism in human liver microsomes by naturally occurring flavonoids. Cancer Res 1981: 41, 67-72.
8. Commandeur JNM, Vermeulen NPE. Molecular and biochemical mechanisms of chemically induced nephrotoxicity: a review. Chem Res Toxicol 1990: 3, 171-194.
9. Ducharme MP, Warbasse LH, Edwards DJ. Disposition of intravenous and oral cyclosporine after administration with grapefruit juice. Clin Pharmacol Ther 1995: 57, 485-491.
10. Edwards DJ, Bernier SM. Naringin and naringenin are not the primary CYP3 A inhibitors in grapefruit juice. Life Sci 1996: 59, 1025-1030.
11. Edwards DJ, Bellevue III FH, Woster PM. Identification of 6′, 7′-dihydrobergamottin, a cytochrome P450 inhibitor, in grapefruit juice. Drug Metab Dispos 1996: 24, 1287-1290.
12. Essigman JM, Croy RG, Bennett RA, Wogan GN. Metabolic activation of aflatoxin B1: patterns of DNA adduct formation, removal, and excretion in relation to carcinogenesis. Drug Metab Rev 1982: 13, 581-602.
13. Fukuda K, Ohta T, Yamazoe Y. Grapefruit component interacting with rat and human P450 CYP3 A: possible involvement of non-flavonoid components in drug interaction. Biol Pharm Bull 1997: 20, 560-564.
14. Fuhr U, Kummert AL. The fate of naringin in humans: a key to grapefruit juice-drug interactions? Clin Pharmacol Ther 1995: 58, 365-373.
15. Gonzalez FJ. Human cytochromes P450: problems and prospects. Trends Pharmacol Sci 1992: 13, 346-352.
16. Guengerich FP. Studies on the activation of a model furan compound-toxicity and covalent binding of 2-(N-ethylcarbamoylhydroxymethyl)furan. Biochem Pharmacol 1977: 26, 1909-1915.
17. 1 activation in human liver microsomes by naringenin and other flavonoids. Carcinogenesis 1990: 11, 2275-2279.
18. Ha HR, Chen J, Leuenberger PM, Freiburghaus AU, Follath F. In vitro inhibition of midazolam and quinidine metabolism by flavonoids. Eur J Clin Pharmacol 1995: 48, 367-371.
19. Hukkinen SK, Varhe A, Olkkola KT, Neuvonen PJ. Plasma concentrations of triazolam are increased by concomitant ingestion of grapefruit juice. Clin Pharmacol Ther 1995: 58, 127-131.
20. Jounaidi Y, Hyrailles V, Gervot L, Maurel P. Detection of a CYP3A5 allelic variant: a candidate for the polymorphic expression of the protein? Biochem Biophys Res Commun 1996: 221, 466-470.
21. Karlsson KE. Deuterium oxide as a reagent for the modification of mass spectra in electrospray microcolumn liquid chromatography - mass spectrometry. J Chromatogr 1993: 647, 31-38.
22. Kawano S, Kamataki T, Yasumori T, Yamazoe Y, Kato R. Purification of human liver cytochrome P-450 catalyzing testosterone 6β-hydroxylation. J Biochem 1987: 102, 493-501.
23. Kolars JC, Schmiedlin RP, Schuetz JD, Fang C, Watkins PB. Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes. J Clin Invest 1992: 90, 1871-1878.
24. Kupferschmidt HH, Ha HR, Ziegler WH, Meier PJ, Krahenbuhl S. Interaction between grapefruit juice and midazolam in humans. Clin Pharmacol Ther 1995: 58, 20-28.
25. Lown KS, Kolars JC, Thummel KE, Barnett JL, Kunze KL, Wrighton SA, Watkins PB. Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel: lack of prediction by the erythromycin breath test. Drug Metab Dispos 1994: 22, 947-955.
26. Miniscalco A, Lundahl J, Regardh CG, Edgar B, Eriksson UG. Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice. J Pharmacol Exp Ther 1992: 261, 1195-1199.
27. Tinel M, Belghiti J, Descatoire V, Amouyal G, Letteron P, Geneve J, Larrey D, Pessayre D. Inactivation of human liver cytochrome P-450 by the drug methoxsalen and other psoralen derivatives. Biochem Pharmacol 1987: 36, 951-955.
28. Watkins PB, Wrighton SA, Schuetz EG, Molowa DT, Guzelian PS. Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man. J Clin Invest 1987: 80, 1029-1036.
29. Wrighton SA, Vandenbraden M, Stevens JC, Shipley LA, Ring BJ. In vitro methods for assessing human hepatic drug metabolism: their use in drug development. Drug Metab Rev 1993: 25, 453-484.
30. Yee GC, Stanley DL, Pessa LJ, Dalla CT, Beltz SE, Ruiz J, Lowenthal DT. Effect of grapefruit juice on blood cyclosporin concertration. Lancet 1995: 345, 955-956.